TO ALL $RXSF - read the filings and news for yourselves. DO NOT rely on anyone else's interpretation of the disclosures made in those filings, good or bad. Pay attention to the press releases and compare them with what the CEO has said she is going to do. She has been delivering on every single thing she has said she would do since the end of the summer. She also has an OPEN DOOR policy, so if you read something critical of the company, whether blatant or by inference, call Lorraine Yarde, speak to her directly, and you will learn the truths. Her number is at the company website at http://www.rxdrugsafe.com She returns every call and is eager to answer questions.
The company is emerging from a R/S apparently UNSCATHED. They company had its designation "D" removed. The company was approved on its uplift application to the QB. The company just started its sales program, and its with CVS and the CEO already announced initial sales through that program. The CEO announced to have a plan in place by the end of the year to resolve any remaining convertible debt. The products are real and are being sold, the technology is current and in use worldwide, and the market are multi-billion dollar markets within healthcare.
If you see something you don't understand, or if there is a post that seems so opposed to the majority of information put out by the company, call the CEO and ask her why. She returns every call and is eager to speak with shareholders and those non-shareholders that may have questions about the disclosures or other topics.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.